Suppr超能文献

抗生素耐药性感染的流行:美国传染病学会向医学界发出的行动呼吁。

The epidemic of antibiotic-resistant infections: a call to action for the medical community from the Infectious Diseases Society of America.

作者信息

Spellberg Brad, Guidos Robert, Gilbert David, Bradley John, Boucher Helen W, Scheld W Michael, Bartlett John G, Edwards John

机构信息

Division of Infectious Diseases, Harbor-University of California-Los Angeles (UCLA) Medical Center, Torrance, CA 90502, USA.

出版信息

Clin Infect Dis. 2008 Jan 15;46(2):155-64. doi: 10.1086/524891.

Abstract

The ongoing explosion of antibiotic-resistant infections continues to plague global and US health care. Meanwhile, an equally alarming decline has occurred in the research and development of new antibiotics to deal with the threat. In response to this microbial "perfect storm," in 2001, the federal Interagency Task Force on Antimicrobial Resistance released the "Action Plan to Combat Antimicrobial Resistance; Part 1: Domestic" to strengthen the response in the United States. The Infectious Diseases Society of America (IDSA) followed in 2004 with its own report, "Bad Bugs, No Drugs: As Antibiotic Discovery Stagnates, A Public Health Crisis Brews," which proposed incentives to reinvigorate pharmaceutical investment in antibiotic research and development. The IDSA's subsequent lobbying efforts led to the introduction of promising legislation in the 109 th US Congress (January 2005-December 2006). Unfortunately, the legislation was not enacted. During the 110 th Congress, the IDSA has continued to work with congressional leaders on promising legislation to address antibiotic-resistant infection. Nevertheless, despite intensive public relations and lobbying efforts, it remains unclear whether sufficiently robust legislation will be enacted. In the meantime, microbes continue to become more resistant, the antibiotic pipeline continues to diminish, and the majority of the public remains unaware of this critical situation. The result of insufficient federal funding; insufficient surveillance, prevention, and control; insufficient research and development activities; misguided regulation of antibiotics in agriculture and, in particular, for food animals; and insufficient overall coordination of US (and international) efforts could mean a literal return to the preantibiotic era for many types of infections. If we are to address the antimicrobial resistance crisis, a concerted, grassroots effort led by the medical community will be required.

摘要

抗生素耐药性感染的持续激增继续困扰着全球和美国的医疗保健系统。与此同时,用于应对这一威胁的新型抗生素研发出现了同样令人担忧的下滑。为应对这场微生物“完美风暴”,2001年,联邦抗菌药物耐药性跨部门特别工作组发布了《抗击抗菌药物耐药性行动计划;第一部分:国内》,以加强美国的应对措施。美国传染病学会(IDSA)于2004年发布了自己的报告《有害病菌,无药可用:随着抗生素研发停滞,一场公共卫生危机正在酝酿》,该报告提出了激励措施,以重振制药行业对抗生素研发的投资。IDSA随后的游说努力促使美国第109届国会(2005年1月至2006年12月)引入了有前景的立法。不幸的是,该立法未能颁布。在第110届国会期间,IDSA继续与国会领导人合作,推动有前景的立法以应对抗生素耐药性感染。然而,尽管进行了密集的公关和游说努力,但能否颁布足够有力的立法仍不明朗。与此同时,微生物的耐药性继续增强,抗生素研发渠道持续减少,而大多数公众仍然没有意识到这一危急情况。联邦资金不足、监测、预防和控制不力、研发活动不足、对农业领域尤其是食用动物抗生素的监管不当,以及美国(和国际)各方努力的总体协调不足,其结果可能意味着许多类型的感染将真的回到抗生素出现之前的时代。如果我们要应对抗菌药物耐药性危机,将需要由医学界牵头开展一场协调一致的基层行动。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验